The forecast for female breast malignant neoplasms mortality in the UK predicts a steady increase in deaths from 11,610 in 2024 to 11,740 by 2028. Year-on-year variations show minor increments, indicating a gradual rise in mortality figures.
From 2024 to 2028, the compound annual growth rate (CAGR) suggests a modest yearly increase reflecting persistent health challenges despite progress in detection and treatment strategies.
Future trends to watch for include advancements in personalized medicine, improved early detection techniques, and the impact of public health policies focused on prevention and education, which may alter these forecasts positively in the long term.
